Results 111 to 120 of about 2,570 (180)

Adaptive Fisher's method using weakly geometric grid for combining <i>p</i>-values with application to COVID-19 surveillance. [PDF]

J R Stat Soc Ser C Appl Stat
Fang Y, Ren Z, Tseng GC.
europepmc   +1 more source

Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancer. [PDF]

Ann Med
Su L, Lin P, Yin Y, Ye Z, Zhuo C, Wei S, Yu S, Li J, Hong Y, Zheng L, Zhao S, Chen Y, Li H, Lin R.   +13 more
europepmc   +1 more source

TL-HDMR: a transfer learning framework for advancing equitable causal inference reveals metabolic signatures of stroke across multiple ancestries. [PDF]

Brief Bioinform
Hou L, Zhou XH, Xue F, Chen H.
europepmc   +1 more source

FunDiff: diffusion models over function spaces for physics-informed generative modeling. [PDF]

Nat Commun
Wang S, Dou Z, Shan S, Liu TR, Lu L.
europepmc   +1 more source

irAE.AI: AI-powered exploration of real-world immune-related adverse events. [PDF]

JAMIA Open
Fort G, Stone D, Lin CN, Young A, Tan AC.   +4 more
europepmc   +1 more source

Quantum Shannon Information Theory-Design of Communication, Ciphers, and Sensors. [PDF]

Entropy (Basel)
Hirota O.
europepmc   +1 more source

A Benchmark and Basis-Set Extrapolation Study of Hyperfine Coupling Constants from the Random Phase Approximation and σ-Functionals. [PDF]

J Phys Chem A
Graf D, Liu L, Siekmann F, Drontschenko V, Ochsenfeld C.   +4 more
europepmc   +1 more source

Efficacy and safety of camrelizumab plus apatinib in advanced urachal cancer (RUN-SC-0102): a single-arm, multicentre, phase 2 trial in China. [PDF]

EClinicalMedicine
Ju M, Li W, Hu L, Ye X, Yan W, Zhang S.
europepmc   +1 more source

Protocol and statistical designs in classic clinical research-toripalimab series trial analysis. [PDF]

Cancer Biol Med
He Y, Bian L, Jiang Z.
europepmc   +1 more source

Learn Then Decide: A Learning Approach for Designing Data Marketplaces. [PDF]

J Am Stat Assoc
Gao Y, Xu W, Zhou JJ, Zhou H, Chen Y, Dai X.   +5 more
europepmc   +1 more source